Linnaeus Bioscience provides a variety of antimicrobial assays including its revolutionary bacterial cytological profiling (BCP) platform, integrated with its proprietary artificial intelligence pipeline, as well as methods to evaluate bacteriophage, antiviral compounds, and cytotoxicity. We are committed to accelerating the discovery efforts of the pharmaceutical industry in the global fight against antibiotic resistant bacteria. Linnaeus Bioscience works with clients on a wide variety of discovery and development projects and designs specific projects or assays to meet the unique needs of its clients.